FIELD: medicine.
SUBSTANCE: invention relates to pyrimidine derivatives having properties of inhibition of replication of HIV of the formula I, as well as pharmaceutical compositions, and the use of the specified compounds for the treatment or prevention of HIV.
EFFECT: new compounds of the formula I are obtained, intended for the treatment and prevention of HIV.
26 cl, 1 tbl, 68 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL REMEDIES FOR TREATMENT AND PREVENTION OF HIV INFECTION | 2021 |
|
RU2780103C1 |
TETRAHYDRO-4N-PYRIDO[1,2-a]PYRIMIDINE AND RELATED COMPOUNDS, USED AS INHIBITORS OF HIV-INTEGRASE | 2003 |
|
RU2329265C2 |
SUBSTITUTED COMPOUNDS OF THIOPHEN AND FURAN-CONDENSED AZOLOPYRIMIDIN-5-(6H)-OH | 2013 |
|
RU2659779C2 |
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER | 2010 |
|
RU2555326C2 |
HETEROCYCLIC COMPOUNDS OR THEIR ACID-ADDITIVE SALTS | 1991 |
|
RU2057754C1 |
CONDENSED PIRIMIDINE DERIVATIVE AND PHARMACEUTICS WITH CRF RELATED ACTIVITY | 2004 |
|
RU2328497C2 |
SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
METHOD FOR PREPARING 5,8,9,10-TETRAHYDROPYRIMIDINO[4,5-d]AZOCINE DERIVATIVES HAVING TRIFLATE, SECONDARY AND TERTIARY AMINO GROUPS IN 4-TH POSITION | 2011 |
|
RU2478637C2 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
Authors
Dates
2022-09-19—Published
2020-02-19—Filed